» Articles » PMID: 687510

Split Dose Cytotoxic Experiments with Misonidazole

Overview
Journal Br J Cancer
Specialty Oncology
Date 1978 Jul 1
PMID 687510
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The toxicity of misonidazole (1-(2-nitroimidazol-1-yl)-3-methoxy-2-propanol) towards mammalian cells in vitro has been determined as a function of O2 tension. Misonidazole under hypoxic conditions (less than 10 Parts/10(6) O2) shows the greatest toxicity. Split-dose experiments indicate that lethal damage can be "repaired" by O2, the magnitude of this repair being time dependent and a function of O2 concentration, with maximum repair in air seen after 2 h at 37 degree C. Unlike radiation damage this repair is not inhibited by modest hyperthermia (41 degrees C) during the split-dose interval. The implication of these results as regards the mechanism of misonidazole toxicity under anaerobic conditions is discussed.

Citing Articles

Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.

Taylor Y, Rauth A Br J Cancer. 1980; 41(6):892-900.

PMID: 7426314 PMC: 2010364. DOI: 10.1038/bjc.1980.166.


Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate.

Mahood J, Willson R Br J Cancer. 1981; 43(3):350-4.

PMID: 7225286 PMC: 2010608. DOI: 10.1038/bjc.1981.55.


Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.

Smith E, Stratford I, Adams G Br J Cancer. 1982; 46(1):117-26.

PMID: 7104191 PMC: 2011057. DOI: 10.1038/bjc.1982.173.


Cell-cycle inhibition by misonidazole of human cells cultivated in vitro under aerobic conditions.

Lindmo T, Pettersen E, Wibe E Br J Cancer. 1979; 40(5):755-60.

PMID: 508579 PMC: 2010116. DOI: 10.1038/bjc.1979.257.


Ascorbate anion potentiates cytotoxicity of nitro-aromatic compounds under hypoxic and anoxic conditions.

Koch C, Howell R, Biaglow J Br J Cancer. 1979; 39(3):321-9.

PMID: 465301 PMC: 2009878. DOI: 10.1038/bjc.1979.56.

References
1.
Watts M . Radiosensitization of hypoxic cells by a nitrofuran; dose-modifying and shoulder effects. Int J Radiat Biol Relat Stud Phys Chem Med. 1977; 31(3):237-50. DOI: 10.1080/09553007714550281. View

2.
Stratford I, Gray P . Some factors affecting the specific toxicity of misonidazole towards hypoxic mammalian cells. Br J Cancer Suppl. 1978; 3:129-31. PMC: 2149360. View

3.
Hall E, Biaglow J . Ro-07-0582 as a radiosensitizer and cytotoxic agent. Int J Radiat Oncol Biol Phys. 1977; 2(5-6):521-30. DOI: 10.1016/0360-3016(77)90163-8. View

4.
Hall E, Astor M, Geard C, Biaglow J . Cytotoxicity of Ro-07-0582; enhancement by hyperthermia and protection by cysteamine. Br J Cancer. 1977; 35(6):809-15. PMC: 2025538. DOI: 10.1038/bjc.1977.122. View

5.
Dische S, Saunders M, Lee M, Adams G, Flockhart I . Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer. 1977; 35(5):567-79. PMC: 2025511. DOI: 10.1038/bjc.1977.90. View